Skip to main content

Stefan Scherer, MD, PhD

Chief Executive Officer & President

Stefan Scherer

Dr. Scherer is physician-scientist with more than 20 years of experience in biopharmaceutical research and development. Before joining 3T, he was president and CEO of ElyxBio, Inc., worked as global head of experimental medicine at Glaxo SmithKline, served as chief medical officer at Cellectis, an allogenic CAR-T company, and was head of early development, strategy, and innovation for U.S. Oncology at Novartis. Prior to Novartis, Dr. Scherer served in key roles at F. Hoffman-La Roche and Genentech, leading the global biomarker and translational medicine department.